Opportunistic protozoan diarrhoea.

Abstract

In the developed world, a significant increase in the incidence of protozoan diarrhoea was observed following the AIDS epidemic. The profound immunodeficiency associated with advanced HIV disease produced increased susceptibility to opportunistic protozoan infections. The resultant profuse diarrhoea, malabsorption and weight loss contributed to the high morbidity and mortality rates associated with the epidemic. The success of highly active antiretroviral therapy (HAART) in suppressing viral replication has led to a reduced incidence of AIDS-related opportunistic infections and this has contributed to decreased morbidity and mortality. In this review, we examine current management practices for HIV-related opportunistic protozoan diarrhoea

• Authors: Yin M Miao, Faith M Awad-El-Kariem, Brian G Gazzard
• Journal: Journal of HIV therapy (J HIV Ther) Vol. 7 Issue 1 Pg. 17-20 (Feb 2002) ISSN: 1462-0308 [Print] England
• PMID: 11956500 (Publication Type: Journal Article, Review)

Chemical References

• Antiprotozoal Agents

Topics

• AIDS-Related Opportunistic Infections (parasitology, prevention & control, therapy)
• Animals
• Antiprotozoal Agents (therapeutic use)
• Antiretroviral Therapy, Highly Active
• Diarrhea (parasitology, prevention & control, therapy)
• HIV Infections (complications, drug therapy)
• Humans
• Intestinal Diseases, Parasitic (parasitology, prevention & control, therapy)
• Protozoan Infections (parasitology, prevention & control, therapy)
• Treatment Outcome